简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2021-11-03 16:42 Personalis Announces Updates to NeXT Platform™ Incorporating Additional Key Profiling Capabilities for Advancing Oncology Biomarkers
2021-11-03 15:17 Nathan Jones, CEO of Xlear, Inc. Statement in Response to a Lawsuit Filed by the Department of Justice, on Behalf of the United States, Alleging That Certain Statements Made by Xlear Violated the FTC Act and the Consumer Protection Act
2021-11-03 13:28 ReValve Solutions, Inc. Announces Successful First Human Use of the Transeptal Mitral Valve Replacement
2021-11-03 11:27 Takeda Applied for Selection of “Prime Market”, Filed Corporate Governance Report With Tokyo Stock Exchange (TSE) in Line With Revised Corporate Governance Code and Published Corporate Governance Related Documents on its Website
2021-11-03 10:47 Philip Morris International Applauds U.K. Government’s Approach to Achieve its Smoke-Free Ambition
2021-11-03 10:00 ZAP Surgical Appoints Industry Veterans to Lead Chinese Market Expansion
2021-11-02 19:24 Masimo Launches Dual SET® Pulse Oximetry
2021-11-02 18:59 Tectonus Limited From New Zealand Wins First Prize
2021-11-02 15:15 Takeda Delivers Strong H1 FY2021 Results; Further Growth Momentum Expected Through Fiscal Year-End Driven by 14 Global Brands
2021-11-01 19:59 Waters and Sartorius Partner to Help Bioprocess Scientists Accelerate Clone Selection and Process Development
2021-11-01 19:54 Frazier Healthcare Partners Announces Several Promotions on Life Sciences Team
2021-11-01 16:38 bit.bio expands Board of Directors with the Appointment of Entrepreneurs and a Nobel Laureate
2021-11-01 15:49 Frazier Healthcare Partners Closes Oversubscribed $830 Million Life Sciences Public Fund
2021-11-01 14:32 Takeda Announces Acquisition of Own Shares
2021-10-29 18:46 Takeda to Acquire GammaDelta Therapeutics to Accelerate Development of Allogeneic γδT Cell Therapies Addressing Solid Tumors
2021-10-29 17:08 Boehringer Ingelheim announces European Medicines Agency’s filing acceptance and validation of marketing authorization application for spesolimab in generalized pustular psoriasis
2021-10-28 19:27 PMI to Commit Additional USD 200 Million to Corporate Venture Capital Activities of PM Equity Partner
2021-10-28 15:01 Solasia and Nippon Kayaku Announce License Agreement in Japan for New Drug Candidate DARINAPARSIN (SP-02)
2021-10-28 09:31 Boehringer Ingelheim and King’s College London Join Forces to Progress New Therapeutic Concepts in Major Depressive Disorder and Schizophrenia
2021-10-27 13:47 Vifor Pharma and Angion report topline results from phase-III registration trial of ANG-3777 in kidney transplant patients at risk for delayed graft function

Business Wire Weibo

Press Releases

Latest Releases